Joint funding through the ARI- AstraZeneca Open Innovation Partnership closing July 31st

Friendly Reminder: The first round of joint funding through the ARI- AstraZeneca Open Innovation Partnership closes July 31st.

Adelaide Research & Innovation Pty Ltd (ARI) and global biopharmaceutical company AstraZeneca have partnered to provide an opportunity for researchers at the University of Adelaide to collaborate with AstraZeneca’s industry-leading scientists and develop new medicines.

This partnership will allow University researchers access to AstraZeneca’s optimized compounds, technologies, multi-disciplinary science, services and know-how, with the aim of joint publications in high profile journals and to see ideas develop into treatments for patients.

Follow the link to register your research project today

This entry was posted in News, Research and tagged , , , . Bookmark the permalink.

Comments are closed.